Login / Signup

Safety of omalizumab treatment in patients with chronic spontaneous urticaria and COVID-19.

Maria PassanteMaddalena NapolitanoStefano DastoliLuigi BennaroGabriella FabbrociniSteven Paul NisticòCataldo Patruno
Published in: Dermatologic therapy (2021)
Keyphrases
  • coronavirus disease
  • sars cov
  • replacement therapy
  • smoking cessation